LINC00200 contributes to the chemoresistance to oxaliplatin of gastric cancer cells via regulating E2F1/RAD51 axis.

Lin, Mengxin; Xu, Meifang; Xu, Zongbin; Weng, Zongqi; Lin, Bingqiang; Lan, Yanqin; Liu, Qing; Lin, Xiaoyan; Pan, Jie

Lin, Mengxin; Xu, Meifang; Xu, Zongbin; Weng, Zongqi; Lin, Bingqiang; Lan, Yanqin; Liu, Qing; Lin, Xiaoyan; Pan, Jie.

Afiliação

Lin M; Department of Oncology, Fujian Medical University Union Hospital, Xinquan Road No. 29, Gulou District, Fuzhou, 350001, Fujian, People's Republic of China.
Xu M; Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, People's Republic of China.
Xu Z; Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, People's Republic of China.
Weng Z; Department of Emergency Surgery, Fujian Medical University Union Hospital, Xinquan Road No. 29, Gulou District, Fuzhou, 350001, Fujian, People's Republic of China.
Lin B; Department of Emergency Surgery, Fujian Medical University Union Hospital, Xinquan Road No. 29, Gulou District, Fuzhou, 350001, Fujian, People's Republic of China.
Lan Y; Department of Oncology, Fujian Medical University Union Hospital, Xinquan Road No. 29, Gulou District, Fuzhou, 350001, Fujian, People's Republic of China.
Liu Q; Department of Oncology, Fujian Medical University Union Hospital, Xinquan Road No. 29, Gulou District, Fuzhou, 350001, Fujian, People's Republic of China.
Lin X; Department of Oncology, Fujian Medical University Union Hospital, Xinquan Road No. 29, Gulou District, Fuzhou, 350001, Fujian, People's Republic of China. wenneituilan@163.com.
Pan J; Department of Emergency Surgery, Fujian Medical University Union Hospital, Xinquan Road No. 29, Gulou District, Fuzhou, 350001, Fujian, People's Republic of China. pjlllj@hotmail.com.

Hum Cell ; 34(4): 1163-1173, 2021 Jul.

Article em En | MEDLINE | ID: mdl-33822325

Assuntos

Resistencia a Medicamentos Antineoplásicos/genética; Fator de Transcrição E2F1/metabolismo; Regulação Neoplásica da Expressão Gênica/genética; RNA Longo não Codificante/genética; RNA Longo não Codificante/metabolismo; Rad51 Recombinase/metabolismo; Neoplasias Gástricas/genética; Neoplasias Gástricas/patologia; Linhagem Celular Tumoral; Expressão Gênica/genética; Humanos; Terapia de Alvo Molecular; Oxaliplatina/farmacologia; Regiões Promotoras Genéticas; RNA Longo não Codificante/fisiologia; Neoplasias Gástricas/tratamento farmacológico; Regulação para Cima/genética

Palavras-chave

Chemoresistance; E2F1; Gastric cancer; LINC00200; RAD51

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Rad51 Recombinase / Fator de Transcrição E2F1 / RNA Longo não Codificante Limite: Humans Idioma: En Revista: Hum Cell Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google